Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.48461461 |
2 | positive regulation by symbiont of host defense response (GO:0052509) | 4.40277515 |
3 | modulation by symbiont of host defense response (GO:0052031) | 4.40277515 |
4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.40277515 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.40277515 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.40277515 |
7 | modulation by symbiont of host immune response (GO:0052553) | 4.40277515 |
8 | response to peptidoglycan (GO:0032494) | 4.29306762 |
9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.26622563 |
10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.21075389 |
11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.11828019 |
12 | negative regulation of cell killing (GO:0031342) | 4.11828019 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.98938835 |
14 | detection of other organism (GO:0098543) | 3.94784027 |
15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.94432709 |
16 | detection of bacterium (GO:0016045) | 3.80759102 |
17 | macrophage activation involved in immune response (GO:0002281) | 3.69856357 |
18 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.66733878 |
19 | neutrophil activation involved in immune response (GO:0002283) | 3.59342497 |
20 | negative regulation of interleukin-12 production (GO:0032695) | 3.56097093 |
21 | immunoglobulin mediated immune response (GO:0016064) | 3.55146771 |
22 | detection of external biotic stimulus (GO:0098581) | 3.45949866 |
23 | protein localization to endosome (GO:0036010) | 3.36845731 |
24 | detection of molecule of bacterial origin (GO:0032490) | 3.35784665 |
25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33102074 |
26 | cellular response to type I interferon (GO:0071357) | 3.32277986 |
27 | type I interferon signaling pathway (GO:0060337) | 3.32277986 |
28 | response to type I interferon (GO:0034340) | 3.32207033 |
29 | NIK/NF-kappaB signaling (GO:0038061) | 3.26084567 |
30 | barbed-end actin filament capping (GO:0051016) | 3.16511987 |
31 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16208701 |
32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.15064546 |
33 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.12684705 |
34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.08393377 |
35 | regulation of mast cell degranulation (GO:0043304) | 3.04517733 |
36 | response to muramyl dipeptide (GO:0032495) | 3.04215840 |
37 | regulation of leukocyte degranulation (GO:0043300) | 3.03015046 |
38 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.99615298 |
39 | mannose metabolic process (GO:0006013) | 2.97767135 |
40 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95726939 |
41 | detection of biotic stimulus (GO:0009595) | 2.94700780 |
42 | response to host immune response (GO:0052572) | 2.94024435 |
43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.94024435 |
44 | germinal center formation (GO:0002467) | 2.93083285 |
45 | glycosphingolipid catabolic process (GO:0046479) | 2.92952810 |
46 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.92181706 |
47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87875513 |
48 | modulation by symbiont of host cellular process (GO:0044068) | 2.83027842 |
49 | response to host (GO:0075136) | 2.82421515 |
50 | response to host defenses (GO:0052200) | 2.82421515 |
51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.82421515 |
52 | myeloid dendritic cell differentiation (GO:0043011) | 2.81033257 |
53 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.79413203 |
54 | cellular extravasation (GO:0045123) | 2.78938961 |
55 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77968572 |
56 | regulation of gamma-delta T cell activation (GO:0046643) | 2.75515935 |
57 | leukocyte aggregation (GO:0070486) | 2.73406238 |
58 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.72906342 |
59 | respiratory burst (GO:0045730) | 2.69416133 |
60 | glycolipid catabolic process (GO:0019377) | 2.66446899 |
61 | T-helper 1 type immune response (GO:0042088) | 2.66087409 |
62 | regulation of necroptotic process (GO:0060544) | 2.65512967 |
63 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.63596334 |
64 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63324264 |
65 | cellular response to virus (GO:0098586) | 2.63180953 |
66 | pinocytosis (GO:0006907) | 2.62813925 |
67 | negative regulation of innate immune response (GO:0045824) | 2.60517289 |
68 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60247107 |
69 | response to laminar fluid shear stress (GO:0034616) | 2.59962058 |
70 | myeloid cell activation involved in immune response (GO:0002275) | 2.59453856 |
71 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.58706262 |
72 | amino sugar catabolic process (GO:0046348) | 2.56886339 |
73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.54169730 |
74 | regulation of antigen processing and presentation (GO:0002577) | 2.53324284 |
75 | regulation of necrotic cell death (GO:0010939) | 2.49049966 |
76 | B cell mediated immunity (GO:0019724) | 2.48960227 |
77 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.48397903 |
78 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.48186060 |
79 | macrophage activation (GO:0042116) | 2.48153443 |
80 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.46885975 |
81 | positive regulation of interferon-alpha production (GO:0032727) | 2.46698706 |
82 | modulation by virus of host process (GO:0019054) | 2.44500027 |
83 | myeloid dendritic cell activation (GO:0001773) | 2.43899231 |
84 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.43512704 |
85 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.42636761 |
86 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.42406168 |
87 | granulocyte activation (GO:0036230) | 2.41955266 |
88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.41748758 |
89 | response to protozoan (GO:0001562) | 2.41474090 |
90 | regulation of interferon-alpha production (GO:0032647) | 2.41351035 |
91 | defense response to protozoan (GO:0042832) | 2.40072360 |
92 | regulation of regulated secretory pathway (GO:1903305) | 2.39247991 |
93 | regulation of superoxide anion generation (GO:0032928) | 2.39135583 |
94 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.38533121 |
95 | Golgi transport vesicle coating (GO:0048200) | 2.37282655 |
96 | COPI coating of Golgi vesicle (GO:0048205) | 2.37282655 |
97 | positive regulation of type 2 immune response (GO:0002830) | 2.35930105 |
98 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.34286924 |
99 | negative regulation of necroptotic process (GO:0060546) | 2.33893841 |
100 | interferon-gamma secretion (GO:0072643) | 2.33607126 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.23215259 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.06698538 |
3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.76508660 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.55072867 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 2.43915975 |
6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.39971348 |
7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.38799832 |
8 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.36526136 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19905653 |
10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18510622 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16440796 |
12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.12740378 |
13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08221104 |
14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05057104 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04103185 |
16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02462252 |
17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.01976000 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01806588 |
19 | MAF_26560356_Chip-Seq_TH1_Human | 1.94015373 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91152172 |
21 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.87583444 |
22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87485881 |
23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.84809893 |
24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.84575325 |
25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75643302 |
26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74814246 |
27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73389295 |
28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72939597 |
29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.71411119 |
30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.70169322 |
31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69938329 |
32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69425502 |
33 | MAF_26560356_Chip-Seq_TH2_Human | 1.68592618 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68467363 |
35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68362977 |
36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.67926490 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63363660 |
38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62796087 |
39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49558104 |
40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46219790 |
41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.44718160 |
42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44539851 |
43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43577938 |
44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41170594 |
45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39370949 |
46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.39066926 |
47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38903852 |
48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37070297 |
49 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36976021 |
50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36131874 |
51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35186801 |
52 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.35165759 |
53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33608536 |
54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32624628 |
55 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32357880 |
56 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31165803 |
57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30022096 |
58 | P68_20966046_ChIP-Seq_HELA_Human | 1.29168936 |
59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28402231 |
60 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27290231 |
61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25224728 |
62 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24366323 |
63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23957616 |
64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23877619 |
65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23798311 |
66 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22489254 |
67 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21802371 |
68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21346400 |
69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21152473 |
70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19283782 |
71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19030584 |
72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18466026 |
73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16412660 |
74 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15714335 |
75 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15270216 |
76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14025785 |
77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13487039 |
78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13287133 |
79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12895535 |
80 | MYB_26560356_Chip-Seq_TH1_Human | 1.12874702 |
81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11900183 |
82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10937494 |
83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10661924 |
84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10659974 |
85 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09585764 |
86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08141670 |
87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05807961 |
88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05356813 |
89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05285294 |
90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03810988 |
91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02661235 |
92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02043806 |
93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01364132 |
94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00603896 |
95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00401375 |
96 | MYB_26560356_Chip-Seq_TH2_Human | 1.00320278 |
97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99716151 |
98 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99184954 |
99 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98736180 |
100 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98484448 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 3.84315100 |
2 | MP0005058_abnormal_lysosome_morphology | 3.54931066 |
3 | MP0005451_abnormal_body_composition | 3.43620562 |
4 | MP0003436_decreased_susceptibility_to | 3.27810550 |
5 | MP0009840_abnormal_foam_cell | 3.13661432 |
6 | MP0003724_increased_susceptibility_to | 2.91160008 |
7 | MP0003191_abnormal_cellular_cholesterol | 2.72766312 |
8 | MP0001835_abnormal_antigen_presentation | 2.68978278 |
9 | MP0003300_gastrointestinal_ulcer | 2.38572707 |
10 | MP0002419_abnormal_innate_immunity | 2.36373520 |
11 | MP0005025_abnormal_response_to | 2.27193526 |
12 | MP0009785_altered_susceptibility_to | 2.25221292 |
13 | MP0005387_immune_system_phenotype | 2.23566329 |
14 | MP0001790_abnormal_immune_system | 2.23566329 |
15 | MP0003705_abnormal_hypodermis_morpholog | 2.17066692 |
16 | MP0000685_abnormal_immune_system | 2.16237347 |
17 | MP0008260_abnormal_autophagy | 2.12034206 |
18 | MP0005000_abnormal_immune_tolerance | 2.11628787 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.02036588 |
20 | MP0003172_abnormal_lysosome_physiology | 2.00845890 |
21 | MP0006082_CNS_inflammation | 2.00464577 |
22 | MP0004510_myositis | 2.00430155 |
23 | MP0004947_skin_inflammation | 1.96315511 |
24 | MP0001800_abnormal_humoral_immune | 1.93804696 |
25 | MP0002452_abnormal_antigen_presenting | 1.93335880 |
26 | MP0002723_abnormal_immune_serum | 1.86684823 |
27 | MP0005464_abnormal_platelet_physiology | 1.80491577 |
28 | MP0009278_abnormal_bone_marrow | 1.79138857 |
29 | MP0001819_abnormal_immune_cell | 1.78545828 |
30 | MP0002420_abnormal_adaptive_immunity | 1.78407800 |
31 | MP0001533_abnormal_skeleton_physiology | 1.75258234 |
32 | MP0005671_abnormal_response_to | 1.74417522 |
33 | MP0003453_abnormal_keratinocyte_physiol | 1.73328627 |
34 | MP0003763_abnormal_thymus_physiology | 1.70973549 |
35 | MP0000858_altered_metastatic_potential | 1.67552642 |
36 | MP0010155_abnormal_intestine_physiology | 1.65750497 |
37 | MP0000343_altered_response_to | 1.58662006 |
38 | MP0001849_ear_inflammation | 1.57024884 |
39 | MP0003806_abnormal_nucleotide_metabolis | 1.54638917 |
40 | MP0009333_abnormal_splenocyte_physiolog | 1.52201034 |
41 | MP0010234_abnormal_vibrissa_follicle | 1.51666926 |
42 | MP0001845_abnormal_inflammatory_respons | 1.49794635 |
43 | MP0002998_abnormal_bone_remodeling | 1.45952168 |
44 | MP0003075_altered_response_to | 1.41787782 |
45 | MP0002405_respiratory_system_inflammati | 1.39965103 |
46 | MP0003828_pulmonary_edema | 1.36787398 |
47 | MP0000716_abnormal_immune_system | 1.34899789 |
48 | MP0003566_abnormal_cell_adhesion | 1.33056522 |
49 | MP0008469_abnormal_protein_level | 1.31855283 |
50 | MP0002398_abnormal_bone_marrow | 1.29279336 |
51 | MP0003183_abnormal_peptide_metabolism | 1.26820317 |
52 | MP0002877_abnormal_melanocyte_morpholog | 1.26010001 |
53 | MP0002132_abnormal_respiratory_system | 1.23224159 |
54 | MP0000604_amyloidosis | 1.22405301 |
55 | MP0003091_abnormal_cell_migration | 1.22069084 |
56 | MP0005397_hematopoietic_system_phenotyp | 1.19156548 |
57 | MP0001545_abnormal_hematopoietic_system | 1.19156548 |
58 | MP0009764_decreased_sensitivity_to | 1.16854011 |
59 | MP0002722_abnormal_immune_system | 1.14930475 |
60 | MP0002429_abnormal_blood_cell | 1.14253711 |
61 | MP0005166_decreased_susceptibility_to | 1.13985287 |
62 | MP0008004_abnormal_stomach_pH | 1.11652778 |
63 | MP0000490_abnormal_crypts_of | 1.11295079 |
64 | MP0000689_abnormal_spleen_morphology | 1.08726220 |
65 | MP0001853_heart_inflammation | 1.05227641 |
66 | MP0000465_gastrointestinal_hemorrhage | 1.03763729 |
67 | MP0002796_impaired_skin_barrier | 1.03331976 |
68 | MP0002139_abnormal_hepatobiliary_system | 1.00044713 |
69 | MP0003656_abnormal_erythrocyte_physiolo | 0.99970831 |
70 | MP0002254_reproductive_system_inflammat | 0.99521245 |
71 | MP0004381_abnormal_hair_follicle | 0.99035062 |
72 | MP0003866_abnormal_defecation | 0.94443697 |
73 | MP0005257_abnormal_intraocular_pressure | 0.90701382 |
74 | MP0003329_amyloid_beta_deposits | 0.89242596 |
75 | MP0000703_abnormal_thymus_morphology | 0.87450442 |
76 | MP0003448_altered_tumor_morphology | 0.87308263 |
77 | MP0005310_abnormal_salivary_gland | 0.86919245 |
78 | MP0000747_muscle_weakness | 0.86058337 |
79 | MP0005023_abnormal_wound_healing | 0.85855429 |
80 | MP0005164_abnormal_response_to | 0.85679978 |
81 | MP0005390_skeleton_phenotype | 0.85103162 |
82 | MP0002138_abnormal_hepatobiliary_system | 0.85037293 |
83 | MP0004883_abnormal_blood_vessel | 0.84659218 |
84 | MP0005076_abnormal_cell_differentiation | 0.83951810 |
85 | MP0001873_stomach_inflammation | 0.83252663 |
86 | MP0004858_abnormal_nervous_system | 0.81732617 |
87 | MP0003795_abnormal_bone_structure | 0.79420341 |
88 | MP0005501_abnormal_skin_physiology | 0.78208547 |
89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77899414 |
90 | MP0000750_abnormal_muscle_regeneration | 0.77287511 |
91 | MP0001851_eye_inflammation | 0.75921017 |
92 | MP0005409_darkened_coat_color | 0.74945756 |
93 | MP0004264_abnormal_extraembryonic_tissu | 0.74856716 |
94 | MP0001216_abnormal_epidermal_layer | 0.74814154 |
95 | MP0002396_abnormal_hematopoietic_system | 0.74664344 |
96 | MP0002332_abnormal_exercise_endurance | 0.72500646 |
97 | MP0001663_abnormal_digestive_system | 0.72333655 |
98 | MP0004185_abnormal_adipocyte_glucose | 0.71941100 |
99 | MP0004233_abnormal_muscle_weight | 0.71571330 |
100 | MP0009763_increased_sensitivity_to | 0.71211361 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.72857583 |
2 | Abnormality of macrophages (HP:0004311) | 4.25692758 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.13973225 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.13973225 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.13973225 |
6 | Recurrent abscess formation (HP:0002722) | 3.80480431 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.79066796 |
8 | Orchitis (HP:0100796) | 3.20541572 |
9 | Myositis (HP:0100614) | 3.19278274 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 3.16760966 |
11 | Dysostosis multiplex (HP:0000943) | 3.07794324 |
12 | Systemic lupus erythematosus (HP:0002725) | 2.95620597 |
13 | Colitis (HP:0002583) | 2.94928246 |
14 | Increased cerebral lipofuscin (HP:0011813) | 2.88223552 |
15 | Loss of speech (HP:0002371) | 2.86502814 |
16 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84953406 |
17 | Obstructive lung disease (HP:0006536) | 2.84953406 |
18 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78042521 |
19 | Cellulitis (HP:0100658) | 2.77149968 |
20 | Increased IgE level (HP:0003212) | 2.72439436 |
21 | Vacuolated lymphocytes (HP:0001922) | 2.71619270 |
22 | Vertebral compression fractures (HP:0002953) | 2.61329606 |
23 | Optic neuritis (HP:0100653) | 2.61292309 |
24 | Retrobulbar optic neuritis (HP:0100654) | 2.61292309 |
25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.57722787 |
26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.50807499 |
27 | Petechiae (HP:0000967) | 2.46818212 |
28 | Gastrointestinal inflammation (HP:0004386) | 2.45657541 |
29 | Axonal loss (HP:0003447) | 2.44210163 |
30 | Gingivitis (HP:0000230) | 2.44189426 |
31 | Inflammation of the large intestine (HP:0002037) | 2.43078347 |
32 | Gastrointestinal infarctions (HP:0005244) | 2.41051344 |
33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.39608067 |
34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.39608067 |
35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.39608067 |
36 | Urticaria (HP:0001025) | 2.39507252 |
37 | Meningitis (HP:0001287) | 2.36301032 |
38 | Interstitial pulmonary disease (HP:0006530) | 2.35795614 |
39 | Mucopolysacchariduria (HP:0008155) | 2.34957498 |
40 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34957498 |
41 | Recurrent fungal infections (HP:0002841) | 2.34433475 |
42 | Amyloidosis (HP:0011034) | 2.29228920 |
43 | Recurrent skin infections (HP:0001581) | 2.29019487 |
44 | Spontaneous hematomas (HP:0007420) | 2.27986741 |
45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27272419 |
46 | Increased serum ferritin (HP:0003281) | 2.24978354 |
47 | Hypertensive crisis (HP:0100735) | 2.23872908 |
48 | Purpura (HP:0000979) | 2.23802038 |
49 | Thin bony cortex (HP:0002753) | 2.18101378 |
50 | Vasculitis (HP:0002633) | 2.16243362 |
51 | Hemorrhage of the eye (HP:0011885) | 2.10703957 |
52 | Distal lower limb muscle weakness (HP:0009053) | 2.09651137 |
53 | Recurrent viral infections (HP:0004429) | 2.08161813 |
54 | Thoracic kyphosis (HP:0002942) | 2.05897797 |
55 | Keratoconjunctivitis sicca (HP:0001097) | 2.05672336 |
56 | Distal lower limb amyotrophy (HP:0008944) | 2.03479925 |
57 | Hepatosplenomegaly (HP:0001433) | 2.01882824 |
58 | Myocardial infarction (HP:0001658) | 2.00227210 |
59 | Hypergammaglobulinemia (HP:0010702) | 1.96309521 |
60 | Increased IgM level (HP:0003496) | 1.96287701 |
61 | Pustule (HP:0200039) | 1.95973163 |
62 | Gastrointestinal stroma tumor (HP:0100723) | 1.93494577 |
63 | Neuronal loss in central nervous system (HP:0002529) | 1.93328503 |
64 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92434753 |
65 | Upper motor neuron abnormality (HP:0002127) | 1.92278321 |
66 | Cerebral aneurysm (HP:0004944) | 1.91147871 |
67 | Abnormality of the nasal mucosa (HP:0000433) | 1.88085632 |
68 | Increased connective tissue (HP:0009025) | 1.87964057 |
69 | Malnutrition (HP:0004395) | 1.87237083 |
70 | Granulocytopenia (HP:0001913) | 1.86692078 |
71 | Osteomyelitis (HP:0002754) | 1.86477934 |
72 | Abnormality of the thoracic spine (HP:0100711) | 1.86114481 |
73 | Bone pain (HP:0002653) | 1.84916620 |
74 | Pulmonary infiltrates (HP:0002113) | 1.83983268 |
75 | Epistaxis (HP:0000421) | 1.82775854 |
76 | Hypertriglyceridemia (HP:0002155) | 1.82205535 |
77 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81875481 |
78 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81875481 |
79 | Premature loss of primary teeth (HP:0006323) | 1.80777221 |
80 | Polycythemia (HP:0001901) | 1.79453779 |
81 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79225868 |
82 | Achilles tendon contracture (HP:0001771) | 1.78899515 |
83 | Peritonitis (HP:0002586) | 1.78653548 |
84 | Emphysema (HP:0002097) | 1.77623519 |
85 | Ragged-red muscle fibers (HP:0003200) | 1.77091433 |
86 | Restrictive lung disease (HP:0002091) | 1.76253590 |
87 | Abnormality of the peritoneum (HP:0002585) | 1.75450077 |
88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.74350166 |
89 | Asymmetric septal hypertrophy (HP:0001670) | 1.74038012 |
90 | Progressive neurologic deterioration (HP:0002344) | 1.73987936 |
91 | Increased variability in muscle fiber diameter (HP:0003557) | 1.73523634 |
92 | Stomatitis (HP:0010280) | 1.71966432 |
93 | Cardiomegaly (HP:0001640) | 1.71836758 |
94 | Polygenic inheritance (HP:0010982) | 1.71808168 |
95 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.71781478 |
96 | Exercise-induced myalgia (HP:0003738) | 1.71723922 |
97 | Keratoconjunctivitis (HP:0001096) | 1.70111926 |
98 | Chest pain (HP:0100749) | 1.69805594 |
99 | Hyperacusis (HP:0010780) | 1.69642846 |
100 | Arterial thrombosis (HP:0004420) | 1.69641865 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.76624016 |
2 | PRPF4B | 3.14821366 |
3 | TRIB3 | 2.93330167 |
4 | IRAK3 | 2.89289052 |
5 | NME2 | 2.78295161 |
6 | RIPK4 | 2.72625201 |
7 | MAP4K1 | 2.47321917 |
8 | BLK | 2.29200594 |
9 | MAP2K3 | 2.19721401 |
10 | SIK1 | 2.08568905 |
11 | TYK2 | 2.03589093 |
12 | MAP3K11 | 1.91876036 |
13 | SMG1 | 1.85561517 |
14 | IRAK4 | 1.83938748 |
15 | TESK2 | 1.82929566 |
16 | ICK | 1.79804815 |
17 | MAP3K3 | 1.75936989 |
18 | TBK1 | 1.74021579 |
19 | CSK | 1.71306159 |
20 | TAOK2 | 1.65359129 |
21 | EPHB1 | 1.65339274 |
22 | MAP3K1 | 1.58172863 |
23 | ARAF | 1.55997590 |
24 | TAOK1 | 1.50416652 |
25 | MAP3K13 | 1.47838373 |
26 | MAP3K14 | 1.46597907 |
27 | RIPK1 | 1.46186705 |
28 | ZAP70 | 1.44644684 |
29 | PIM2 | 1.27394861 |
30 | MARK3 | 1.27271003 |
31 | TESK1 | 1.24459316 |
32 | SIK3 | 1.20243794 |
33 | KSR2 | 1.16592629 |
34 | CDC42BPA | 1.15418237 |
35 | IRAK2 | 1.14813607 |
36 | FGFR4 | 1.14090901 |
37 | EPHA2 | 1.13736531 |
38 | BTK | 1.10539656 |
39 | JAK3 | 1.10083306 |
40 | TTN | 1.08752535 |
41 | GRK6 | 1.08742083 |
42 | TGFBR2 | 1.05452944 |
43 | FGR | 0.99038329 |
44 | PAK4 | 0.96188305 |
45 | JAK1 | 0.95112278 |
46 | IKBKE | 0.94780926 |
47 | MOS | 0.92424894 |
48 | EEF2K | 0.91789362 |
49 | PRKD2 | 0.88121527 |
50 | PKN2 | 0.87931464 |
51 | HCK | 0.87341348 |
52 | PTK6 | 0.87273711 |
53 | CSF1R | 0.87141397 |
54 | SIK2 | 0.87119171 |
55 | PDPK1 | 0.87097356 |
56 | FES | 0.85980440 |
57 | MARK2 | 0.85513038 |
58 | LRRK2 | 0.84581281 |
59 | MAP3K10 | 0.83398407 |
60 | JAK2 | 0.82392775 |
61 | MATK | 0.81855114 |
62 | IKBKB | 0.78227484 |
63 | MAP3K6 | 0.74874235 |
64 | MAPK11 | 0.71005261 |
65 | TNK2 | 0.70932750 |
66 | HIPK2 | 0.70662761 |
67 | STK10 | 0.68469048 |
68 | SYK | 0.65799151 |
69 | MAP3K8 | 0.64733517 |
70 | DYRK1B | 0.63147959 |
71 | LYN | 0.63129885 |
72 | DDR2 | 0.61610162 |
73 | RPS6KA2 | 0.61232687 |
74 | MAPK12 | 0.60702922 |
75 | CDK12 | 0.60201302 |
76 | BMX | 0.57138051 |
77 | RAF1 | 0.56922880 |
78 | PDK1 | 0.56645980 |
79 | BRAF | 0.56107163 |
80 | MAP3K5 | 0.54597610 |
81 | RET | 0.53481878 |
82 | RPS6KC1 | 0.52823882 |
83 | RPS6KL1 | 0.52823882 |
84 | ABL2 | 0.52002227 |
85 | GRK7 | 0.48125637 |
86 | LCK | 0.48124232 |
87 | BMPR2 | 0.47966620 |
88 | MAPKAPK2 | 0.47136493 |
89 | MTOR | 0.46997704 |
90 | MAP3K2 | 0.45577656 |
91 | MST1R | 0.45325924 |
92 | PRKG2 | 0.44182470 |
93 | MAPKAPK3 | 0.43992320 |
94 | PAK1 | 0.43901618 |
95 | CDK4 | 0.43420444 |
96 | PDGFRA | 0.42612671 |
97 | CHUK | 0.37132399 |
98 | CLK1 | 0.36711053 |
99 | KIT | 0.36193588 |
100 | IRAK1 | 0.34866223 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.11236030 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45938743 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.42699393 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.34295999 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33531446 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.07383354 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.03235889 |
8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02565439 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 1.98976114 |
10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.95475740 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.87432333 |
12 | Lysosome_Homo sapiens_hsa04142 | 1.81344981 |
13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.79363526 |
14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77769473 |
15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.72574885 |
16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69986428 |
17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.67936836 |
18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64091783 |
19 | Influenza A_Homo sapiens_hsa05164 | 1.52793187 |
20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.52262531 |
21 | Phagosome_Homo sapiens_hsa04145 | 1.51988097 |
22 | Malaria_Homo sapiens_hsa05144 | 1.51163414 |
23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.42037828 |
24 | Apoptosis_Homo sapiens_hsa04210 | 1.39788598 |
25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39589868 |
26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39427531 |
27 | Asthma_Homo sapiens_hsa05310 | 1.38499800 |
28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37821879 |
29 | Hepatitis C_Homo sapiens_hsa05160 | 1.37274369 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36480246 |
31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34621282 |
32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32156532 |
33 | Hepatitis B_Homo sapiens_hsa05161 | 1.30871485 |
34 | Salmonella infection_Homo sapiens_hsa05132 | 1.28985791 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.28048734 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27431152 |
37 | Measles_Homo sapiens_hsa05162 | 1.25267566 |
38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.24017860 |
39 | Bladder cancer_Homo sapiens_hsa05219 | 1.23191539 |
40 | Shigellosis_Homo sapiens_hsa05131 | 1.22100157 |
41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.20812872 |
42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20767956 |
43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20605416 |
44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18768854 |
45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.15444947 |
46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15386561 |
47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13644636 |
48 | Legionellosis_Homo sapiens_hsa05134 | 1.13575485 |
49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08460126 |
50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04469565 |
51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03596190 |
52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03086736 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01591255 |
54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01496159 |
55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99303539 |
56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95661636 |
57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95100055 |
58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94612158 |
59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94505430 |
60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94442919 |
61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90360048 |
62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90285302 |
63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87411881 |
64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84387339 |
65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83967036 |
66 | Endocytosis_Homo sapiens_hsa04144 | 0.81765308 |
67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80517162 |
68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79412979 |
69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78943984 |
70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76787426 |
71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75074871 |
72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75014789 |
73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71134292 |
74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69501804 |
75 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69485370 |
76 | Amoebiasis_Homo sapiens_hsa05146 | 0.68485485 |
77 | Prion diseases_Homo sapiens_hsa05020 | 0.67734203 |
78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67010161 |
79 | Insulin resistance_Homo sapiens_hsa04931 | 0.66317938 |
80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63649826 |
81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62829896 |
82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59159368 |
83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56622541 |
84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56526877 |
85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56430023 |
86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55975770 |
87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55120650 |
88 | Platelet activation_Homo sapiens_hsa04611 | 0.54559799 |
89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53126566 |
90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49267107 |
91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45208790 |
92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43668085 |
93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43600121 |
94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42564399 |
95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42053011 |
96 | Prostate cancer_Homo sapiens_hsa05215 | 0.42023868 |
97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41936630 |
98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40533369 |
99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38766163 |
100 | Glioma_Homo sapiens_hsa05214 | 0.37810770 |